Reuters: Regulatory News: Hospira recalls pain injection on overdose risk

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

Hospira recalls pain injection on overdose risk Aug 16th 2012, 21:37 Thu Aug 16, 2012 5:37pm EDT Aug 16 (Reuters) - The U.S. Food and Drug Administration said Hospira Inc is voluntarily recalling one lot of its hydromorphone pain relieving injection as it may contain more than the intended fill volume, posing a risk of drug overdose. Overdose of opioid pain medications such as hydromorphone may lead to life-threatening consequences, including slowed breathing, low blood pressure and reduced heart rate, the FDA said. Hospira began the recall on Thursday after a complaint that one Carpuject - the drug delivery system - contained more than the intended 1ml labeled fill volume. The company said it has not received any reports of adverse events related to the affected lot. The number of the affected lot is 12720LL and it was distributed between March and May 2012.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions